Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial
PaperCitations, authors & open-access status
PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 277 citations, 2022 year and closed oa status.
277
Citations
2022
Year
closed
OA Status